The mechanism of ciclosporin immunosuppression.
Lorber
M I
MI
Department of Surgery, Yale University School of Medicine, New Haven, Conn.
D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D003524:Cyclosporins / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D003864:Depression, Chemical; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D008222:Lymphokines / Q000096:biosynthesis; D051379:Mice; D019696:Peptidylprolyl Isomerase; D011485:Protein Binding; D011863:Radioimmunoassay; D051381:Rats; D015375:Receptors, Interleukin-2 / Q000502:physiology; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism
D002352:Carrier Proteins; D003524:Cyclosporins; D008222:Lymphokines; D015375:Receptors, Interleukin-2; D019696:Peptidylprolyl Isomerase